within Pharmacolibrary.Drugs.ATC.S;

model S01AE02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.35,
    Cl             = 0.006,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0019,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 900
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AE02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Norfloxacin is a synthetic, broad-spectrum fluoroquinolone antibiotic used primarily to treat urinary tract infections and some types of eye infections. It acts by inhibiting bacterial DNA gyrase, inhibiting DNA replication. Norfloxacin is approved for use in some countries but has seen reduced use and withdrawals in others due to safety concerns.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers, both sexes, after a single oral dose.</p><h4>References</h4><ol><li><p>Stein, GE (1987). Review of the bioavailability and pharmacokinetics of oral norfloxacin. <i>The American journal of medicine</i> 82(6B) 18–21. DOI:<a href=\"https://doi.org/10.1016/0002-9343(87)90613-9\">10.1016/0002-9343(87)90613-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3300308/\">https://pubmed.ncbi.nlm.nih.gov/3300308</a></p></li><li><p>Wang, Z, et al., &amp; Cheng, B (2022). Pharmacokinetics and residue elimination of norfloxacin in rainbow trout (Oncorhynchus mykiss). <i>Journal of veterinary pharmacology and therapeutics</i> 45(3) 301–310. DOI:<a href=\"https://doi.org/10.1111/jvp.13046\">10.1111/jvp.13046</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35225357/\">https://pubmed.ncbi.nlm.nih.gov/35225357</a></p></li><li><p>Chang, ZQ, et al., &amp; Park, SC (2007). Clinical pharmacokinetics of norfloxacin-glycine acetate after intravenous and oral administration in pigs. <i>Journal of veterinary science</i> 8(4) 353–356. DOI:<a href=\"https://doi.org/10.4142/jvs.2007.8.4.353\">10.4142/jvs.2007.8.4.353</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17993748/\">https://pubmed.ncbi.nlm.nih.gov/17993748</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AE02;
